Pfizer Inc. (PFE) makes a promising vaccine investment
Pfizer Inc. (NYSE: PFE) will collaborate on the development of a potential Lyme disease vaccine. The increasing number of people
Pfizer Inc. (NYSE: PFE) will collaborate on the development of a potential Lyme disease vaccine. The increasing number of people
Pfizer and BioNTech have begun testing the coronavirus vaccine in children younger than 12 years of age with the aim
On Friday, to a basket of benchmark currencies, the dollar index rose 0.1 percent, while the euro also gained 0.14
The latest test results for COVID-19, a vaccine manufactured by biotech company Moderna Inc. (MRNA), were announced late last year. The
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.